Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
Web Only Data thoraxjnl-2011-200393
Files in this Data Supplement:
Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of
Thorax.
View free sample issue >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.